On April 18, 2026, Jade Biosciences appointed Andrew King, BVMS, Ph.D., as President of Research & Development, promoting him from his previous role as Chief Scientific Officer.
Key takeaways
Andrew King was appointed President, Research & Development, effective April 18, 2026.
Dr. King previously served as the Company's Chief Scientific Officer and Head of Research & Development.
The Board of Directors approved the appointment on April 18, 2026.
No changes were made to Dr. King's compensation in connection with this appointment.